Nang Kuang Pharmaceutical Co., Ltd. (TPE:1752)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
36.85
-0.15 (-0.41%)
At close: Mar 6, 2026

Nang Kuang Pharmaceutical Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
3,7213,7674,1565,3836,4533,888
Market Cap Growth
-12.26%-9.36%-22.80%-16.59%65.97%-2.78%
Enterprise Value
4,0404,2034,4355,6816,6514,113
Last Close Price
36.8537.3039.3549.0856.7332.52
PE Ratio
15.2915.4117.0727.1318.3319.83
Forward PE
-17.9317.9317.9317.9317.93
PS Ratio
1.721.741.892.503.332.18
PB Ratio
1.491.511.722.262.681.74
P/TBV Ratio
1.501.521.722.272.681.74
P/FCF Ratio
19.9820.22-119.3623.449.71
P/OCF Ratio
8.028.128.9115.7117.486.99
EV/Sales Ratio
1.871.942.022.643.432.31
EV/EBITDA Ratio
8.448.789.0112.8913.399.49
EV/EBIT Ratio
13.6614.2214.3021.8620.6816.16
EV/FCF Ratio
21.6922.57-125.9824.1610.27
Debt / Equity Ratio
0.260.260.260.300.170.24
Debt / EBITDA Ratio
1.371.371.291.600.821.23
Debt / FCF Ratio
3.533.53-15.651.491.33
Net Debt / Equity Ratio
0.130.130.140.140.000.05
Net Debt / EBITDA Ratio
0.650.650.680.740.010.26
Net Debt / FCF Ratio
1.681.68-5.797.250.020.29
Asset Turnover
0.570.570.570.580.550.53
Inventory Turnover
2.032.031.971.751.631.61
Quick Ratio
0.670.670.630.590.760.72
Current Ratio
1.401.401.271.201.581.39
Return on Equity (ROE)
9.93%9.93%10.14%8.29%15.14%8.82%
Return on Assets (ROA)
4.84%4.84%5.06%4.37%5.73%4.75%
Return on Invested Capital (ROIC)
8.75%8.91%9.12%9.42%11.56%8.91%
Return on Capital Employed (ROCE)
10.70%10.70%11.60%10.10%12.60%10.80%
Earnings Yield
6.57%6.49%5.86%3.69%5.46%5.04%
FCF Yield
5.00%4.95%-1.40%0.84%4.27%10.30%
Dividend Yield
4.34%-4.07%4.08%4.05%5.54%
Payout Ratio
33.05%33.05%82.98%117.07%51.64%82.39%
Buyback Yield / Dilution
-0.16%-0.16%-0.10%0.08%0.01%-0.03%
Total Shareholder Return
4.16%-0.16%3.96%4.15%4.06%5.50%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.